A336040 logo

TASCOM Co.,Ltd. Stock Price

XKON:A336040 Community·₩24.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A336040 Share Price Performance

₩4,200.00
200.00 (5.00%)
₩4,200.00
200.00 (5.00%)
Price ₩4,200.00

A336040 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

TASCOM Co.,Ltd. Key Details

₩0

Revenue

₩0

Cost of Revenue

₩0

Gross Profit

₩0

Other Expenses

₩0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A336040

Founded
2014
Employees
n/a
CEO
InGeun Lee
WebsiteView website
www.yidobio.com

TASCOM Co.,Ltd. engages in the research and development, manufacturing, and sales of in vitro diagnostic medical devices. The company offers SimplexTAS, an in vitro diagnostic medical device for point-of-care diagnosis that can diagnose and monitor various diseases, such as diabetes, hyperlipidemia, liver disease, kidney disease, and infections. It also provides pen needles and syringes. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021. TASCOM Co.,Ltd. was founded in 2014 and is headquartered in Anyang-Si, South Korea.

Recent A336040 News & Updates

Recent updates

No updates